Table 4 The relationship between the mGPS and clinicopathological characteristics in patients with colorectal cancer (n=233)

From: Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

 

mGPS 0 ( n =105)

mGPS 1 ( n =92)

mGPS 2 ( n =36)

P -value

Age (<65/65–74/>75 years)

37/38/30

34/30/28

11/11/14

0.431

Sex (male/female)

62/43

47/45

20/16

0.487

Deprivation (1–2/3–5/6–7)a

6/45/54

4/41/47

2/13/21

0.584

Tumour site (colon/rectum)

54/51

59/33

22/14

0.142

TNM Stage (I/II/III/IV)

15/30/43/17

6/25/17/44

1/7/5/23

<0.001

White cell count (<8.5/8.5–11/>11 × 109 l−1)

75/23/7

37/33/22

10/11/15

<0.001

Neutrophil count (<7.5/>7.5 × 109 l−1)

96/9

65/27

17/19

<0.001

Lymphocyte count (>3.0/1.0–3.0/<1.0 × 109 l−1)

3/97/5

6/74/12

0/26/10

0.002

Monocyte count (<0.9/>0.9 × 109 l−1)

95/10

74/18

24/12

0.001

Platelet count (<400/>400 × 103 l−1)

93/11

62/30

17/18

<0.001

Neutrophil/lymphocyte ratio (<5/>5)

96/9

61/31

15/21

<0.001

  1. TNM=tumour, node, metastases; mGPS=modified Glasgow Prognostic Score.
  2. aIndividual deprivation categories were used in the statistical analysis.
Back to article page